Researchers Control Cancer Treatment With New Innovation: CAR T Switch(blade)

The early study result from Scripps Research suggests that switchable CAR T cells are not only safe to use for patients with B cell cancers, but comparatively safer and more effective than some CAR T therapies currently on the market.

Read the full post at Forbes - Channel Feed
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive